NFID Infectious Diseases Immunization COVID-19 Antibiotic Resistance About Us Donate Search Home About NFID Strategic Partners Strategic Partners Share Tweet Share Email Print For nearly 50 years, NFID has been an innovative thought leader tackling the challenges and minimizing the impact of infectious diseases on US public health. NFID has educated and engaged millions, from families with small children to experienced healthcare professionals to community leaders and policy makers. The NFID Strategic Partners Program enables organizations to engage deeply and to join a pivotal group of leaders in the field of infectious diseases. Specifically, the program offers access, awareness, and advancement. To learn more, view the program brochure. 2021 Strategic Partners Platinum: AstraZeneca Janssen Therapeutics ModernaTX, Inc. Pfizer Inc. Sanofi Pasteur Gold: Merck & Co., Inc. Silver: GSK Seqirus, Inc. USA Takeda Pharmaceuticals USA, Inc. Bronze: Bavarian Nordic VBI Vaccines, Inc. Strategic Partners Program Brochure Program Benefits (2022) Recent Blog Schaffner Report: Widening Circle of Eligibility for COVID-19 Boosters View All National Foundation for Infectious Diseases 7201 Wisconsin Avenue Suite 750 Bethesda, MD 20814 301.656.0003 1629 K Street, NW Suite 300 Washington, DC 20006 Privacy Policy Disclaimer This website is designed to provide education to the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan. All information on this site is for general purposes only, is based on US recommendations, and is not intended to be a substitute for professional medical advice. Federal EIN: 23-7198530 Connect with NFID Subscribe